Form 8-K - Current report:
SEC Accession No. 0001641172-25-011273
Filing Date
2025-05-16
Accepted
2025-05-16 17:00:15
Documents
14
Period of Report
2025-05-13
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 59466
2 EX-10.1 ex10-1.htm EX-10.1 141114
  Complete submission text file 0001641172-25-011273.txt   397288

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE celc-20250514.xsd EX-101.SCH 3015
4 XBRL LABEL FILE celc-20250514_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE celc-20250514_pre.xml EX-101.PRE 22359
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3577
Mailing Address 16305 36TH AVENUE N SUITE 100 MINNEAPOLIS MN 55446
Business Address 16305 36TH AVENUE N SUITE 100 MINNEAPOLIS MN 55446 763-392-0767
Celcuity Inc. (Filer) CIK: 0001603454 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38207 | Film No.: 25960273
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)